HealthStream (NASDAQ:HSTM) Lowered to Sell at BidaskClub

BidaskClub cut shares of HealthStream (NASDAQ:HSTM) from a hold rating to a sell rating in a research report report published on Saturday, BidAskClub reports.

Other research analysts have also recently issued research reports about the stock. Barrington Research restated a market perform rating on shares of HealthStream in a report on Thursday, July 25th. Zacks Investment Research upgraded shares of HealthStream from a hold rating to a strong-buy rating and set a $32.00 target price for the company in a report on Thursday, October 24th. Finally, ValuEngine cut shares of HealthStream from a buy rating to a hold rating in a report on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a strong buy rating to the stock. HealthStream has an average rating of Hold and an average target price of $29.00.

Shares of HSTM stock traded up $0.14 during trading hours on Friday, reaching $27.38. 66,500 shares of the company were exchanged, compared to its average volume of 126,177. HealthStream has a fifty-two week low of $23.06 and a fifty-two week high of $30.00. The stock’s fifty day moving average is $26.74 and its two-hundred day moving average is $26.44. The company has a market cap of $881.99 million, a price-to-earnings ratio of 63.67, a P/E/G ratio of 5.50 and a beta of 0.64. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.24 and a quick ratio of 2.24.

HealthStream (NASDAQ:HSTM) last announced its earnings results on Tuesday, October 22nd. The technology company reported $0.11 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.06 by $0.05. HealthStream had a net margin of 5.92% and a return on equity of 4.14%. The business had revenue of $62.50 million during the quarter, compared to analysts’ expectations of $62.91 million. During the same quarter in the prior year, the company posted $0.09 earnings per share. The firm’s revenue was up 4.3% on a year-over-year basis. On average, research analysts anticipate that HealthStream will post 0.41 earnings per share for the current year.

In other HealthStream news, Director Tate Deborah Taylor sold 6,495 shares of the stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $27.96, for a total value of $181,600.20. Following the completion of the sale, the director now owns 16,181 shares in the company, valued at $452,420.76. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Jeffrey L. Mclaren sold 5,000 shares of the stock in a transaction on Monday, August 12th. The shares were sold at an average price of $28.58, for a total transaction of $142,900.00. Following the completion of the sale, the director now owns 14,193 shares of the company’s stock, valued at approximately $405,635.94. The disclosure for this sale can be found here. Corporate insiders own 20.40% of the company’s stock.

Hedge funds have recently made changes to their positions in the business. Jacobs Levy Equity Management Inc. lifted its stake in HealthStream by 3.2% in the second quarter. Jacobs Levy Equity Management Inc. now owns 172,700 shares of the technology company’s stock valued at $4,466,000 after acquiring an additional 5,320 shares during the last quarter. Panagora Asset Management Inc. lifted its stake in HealthStream by 0.6% in the second quarter. Panagora Asset Management Inc. now owns 391,521 shares of the technology company’s stock valued at $10,125,000 after acquiring an additional 2,426 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in HealthStream by 1.7% in the second quarter. Charles Schwab Investment Management Inc. now owns 150,039 shares of the technology company’s stock valued at $3,881,000 after acquiring an additional 2,522 shares during the last quarter. Resources Investment Advisors LLC. lifted its stake in HealthStream by 13.0% in the second quarter. Resources Investment Advisors LLC. now owns 3,900 shares of the technology company’s stock valued at $101,000 after acquiring an additional 450 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in HealthStream by 0.3% in the second quarter. Vanguard Group Inc. now owns 2,715,533 shares of the technology company’s stock valued at $70,224,000 after acquiring an additional 9,253 shares during the last quarter. Hedge funds and other institutional investors own 71.56% of the company’s stock.

About HealthStream

HealthStream, Inc provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the training, certification, assessment, development, clinical development, talent management, performance appraisal, and other needs, as well as training, implementation, and account management services for the healthcare community.

See Also: What is diluted earnings per share (Diluted EPS)?

Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.